Langham, S, Wright, A, Kenworthy, J, Grieve, R and Dunlop, WC. 2018. Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom: Supplemental Materials. [Online]. Value in Health. Available from: https://doi.org/10.1016/j.jval.2017.07.014
Langham, S, Wright, A, Kenworthy, J, Grieve, R and Dunlop, WC. Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom: Supplemental Materials [Internet]. Value in Health; 2018. Available from: https://doi.org/10.1016/j.jval.2017.07.014
Langham, S, Wright, A, Kenworthy, J, Grieve, R and Dunlop, WC (2018). Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom: Supplemental Materials. [Data Collection]. Value in Health. https://doi.org/10.1016/j.jval.2017.07.014
Description
Input parameters and ranges for Naloxone distribution model parameters, with detailed rationale for parameter selection. Model built in Microsoft Excel 2016 and subsequently reproduced in R version 3.3.2 and validated against the Excel version.
| Data capture method | Simulation |
|---|---|
| Date (Date published in a 3rd party system) | 4 February 2018 |
| Language(s) of written materials | English |
| Data Creators | Langham, S, Wright, A, Kenworthy, J, Grieve, R and Dunlop, WC |
|---|---|
| LSHTM Faculty/Department | Faculty of Public Health and Policy > Dept of Health Services Research and Policy |
| Participating Institutions | Maverex Ltd., Manchester, United Kingdom, Mundipharma International Ltd., Cambridge, United Kingdom, London School of Hygiene & Tropical Medicine, London, United Kingdom |
| Date Deposited | 02 May 2018 16:39 |
|---|---|
| Last Modified | 08 Jul 2021 12:52 |
| Publisher | Value in Health |
